Published in Scand J Infect Dis on January 01, 1983
Prevention and self-treatment of traveler's diarrhea. Clin Microbiol Rev (2006) 1.05
Epidemiological aspects of travel related illness. BMJ (1992) 0.89
The uncounted dead--American civilians dying overseas. Public Health Rep (1992) 0.88
Defining infections in international travellers through the GeoSentinel surveillance network. Nat Rev Microbiol (2009) 0.80
Travel-associated illnesses. J R Soc Med (1988) 0.75
Coughing and fever after surfing in Central America. Wien Klin Wochenschr (2012) 0.75
SEQAID: a DNA sequence assembling program based on a mathematical model. Nucleic Acids Res (1984) 6.91
Haemophilus influenzae type b capsular polysaccharide vaccine in children: a double-blind field study of 100,000 vaccinees 3 months to 5 years of age in Finland. Pediatrics (1977) 4.64
Meningococcal disease: still with us. Rev Infect Dis (1983) 4.36
The protective level of serum antibodies to the capsular polysaccharide of Haemophilus influenzae type b. J Infect Dis (1983) 4.05
Prevention of Hemophilus influenzae type b bacteremic infections with the capsular polysaccharide vaccine. N Engl J Med (1984) 3.37
Clinical efficacy of meningococcus group A capsular polysaccharide vaccine in children three months to five years of age. N Engl J Med (1977) 3.32
A randomized, prospective field trial of a conjugate vaccine in the protection of infants and young children against invasive Haemophilus influenzae type b disease. N Engl J Med (1990) 2.90
Polysaccharide vaccines of group A Neisseria meningtitidis and Haemophilus influenzae type b: a field trial in Finland. J Infect Dis (1977) 2.79
Efficacy of Haemophilus influenzae type b polysaccharide-diphtheria toxoid conjugate vaccine in infancy. N Engl J Med (1987) 2.47
Frequency of true adverse reactions to measles-mumps-rubella vaccine. A double-blind placebo-controlled trial in twins. Lancet (1986) 2.34
Rapid effect on endemic measles, mumps, and rubella of nationwide vaccination programme in Finland. Lancet (1986) 2.21
Vaccination greatly reduces disease, disability, death and inequity worldwide. Bull World Health Organ (2008) 2.16
No evidence for measles, mumps, and rubella vaccine-associated inflammatory bowel disease or autism in a 14-year prospective study. Lancet (1998) 2.01
Prevention of travellers' diarrhoea by oral B-subunit/whole-cell cholera vaccine. Lancet (1991) 1.82
Measles history and atopic diseases: a population-based cross-sectional study. JAMA (2000) 1.81
Use of fluoroquinolones in pediatrics: consensus report of an International Society of Chemotherapy commission. Pediatr Infect Dis J (1995) 1.70
Antibody response to capsular polysaccharides of groups A and C neisseria meningitidis and Haemophilus influenzae type b during bacteremic disease. J Infect Dis (1981) 1.65
Serum antibodies after vaccination with Haemophilus influenzae type b capsular polysaccharide and responses to reimmunization: no evidence of immunologic tolerance or memory. Pediatrics (1984) 1.65
Serious adverse events after measles-mumps-rubella vaccination during a fourteen-year prospective follow-up. Pediatr Infect Dis J (2000) 1.56
Serum antibodies to capsular polysaccharide vaccine of group A Neissera meningitidis followed for three years in infants and children. J Infect Dis (1980) 1.53
Antibody levels achieved in infants by course of Haemophilus influenzae type B polysaccharide/diphtheria toxoid conjugate vaccine. Lancet (1985) 1.52
Narrow- versus broad-spectrum parenteral anatimicrobials against common infections of childhood: a prospective and randomised comparison between penicillin and cefuroxime. Eur J Pediatr (2000) 1.51
Immunoreactivation of Epstein-Barr virus due to cytomegalovirus primary infection. J Med Virol (1998) 1.48
The effect of a recent previous visit to a physician on outcome after childhood bacterial meningitis. JAMA (1994) 1.48
Serum C-reactive protein, erythrocyte sedimentation rate, and white blood cell count in acute hematogenous osteomyelitis of children. Pediatrics (1994) 1.40
Severity of childhood bacterial meningitis and duration of illness before diagnosis. Lancet (1991) 1.39
Meningococcal disease in Scandinavia. Br Med J (Clin Res Ed) (1982) 1.35
Meningococcal disease in Europe: epidemiology, mortality, and prevention with conjugate vaccines. Report of a European advisory board meeting Vienna, Austria, 6-8 October, 2000. Vaccine (2001) 1.34
Evaluation of two tetravalent (ACYW135) meningococcal vaccines in infants and small children: a clinical study comparing immunogenicity of O-acetyl-negative and O-acetyl-positive group C polysaccharides. Pediatrics (1985) 1.34
Changes in erythrocyte sedimentation rate and C-reactive protein after total hip arthroplasty. Clin Orthop Relat Res (1984) 1.31
Serum C-reactive protein, erythrocyte sedimentation rate and white blood cell count in septic arthritis of children. Pediatr Infect Dis J (1997) 1.28
C-reactive protein in rapid differentiation of acute epiglottitis from spasmodic croup and acute laryngotracheitis: a preliminary report. J Pediatr (1983) 1.25
Seasonal variation in etiology of travelers' diarrhea. Finnish-Moroccan Study Group. J Infect Dis (1992) 1.22
Shift in the age-distribution of meningococcal disease as predictor of an epidemic? Lancet (1982) 1.21
Epidemiology of invasive Haemophilus influenzae type b disease among children in Finland before vaccination with Haemophilus influenzae type b conjugate vaccine. Pediatr Infect Dis J (1989) 1.20
Etiology of measles- and rubella-like illnesses in measles, mumps, and rubella-vaccinated children. J Infect Dis (1998) 1.20
Vaccination against meningococcal group A disease in Finland 1974-75. Scand J Infect Dis (1976) 1.19
Group A meningococcal polysaccharide vaccine and course of the group A meningococcal epidemic in Finland. Scand J Infect Dis (1978) 1.19
Childhood bacterial meningitis: initial symptoms and signs related to age, and reasons for consulting a physician. Eur J Pediatr (1987) 1.19
C reactive protein in the evaluation of febrile illness. Arch Dis Child (1986) 1.16
Short-term treatment of traveler's diarrhea with norfloxacin: a double-blind, placebo-controlled study during two seasons. Clin Infect Dis (1993) 1.15
Oral glycerol and intravenous dexamethasone in preventing neurologic and audiologic sequelae of childhood bacterial meningitis. The Finnish Study Group. Pediatr Infect Dis J (1995) 1.14
Reappraisal of lung tap: review of an old method for better etiologic diagnosis of childhood pneumonia. Clin Infect Dis (2001) 1.11
Secondary measles vaccine failures identified by measurement of IgG avidity: high occurrence among teenagers vaccinated at a young age. Epidemiol Infect (2000) 1.10
Explosive school-based measles outbreak: intense exposure may have resulted in high risk, even among revaccinees. Am J Epidemiol (1998) 1.10
Clinical "pneumococcal pneumonia" due to Moraxella osloensis: case report and a review. Scand J Infect Dis (2001) 1.09
Fever, C-reactive protein, and erythrocyte sedimentation rate in monitoring recovery from septic arthritis: a preliminary study. J Pediatr Orthop (1984) 1.08
C-reactive protein compared with white blood cell count and erythrocyte sedimentation rate in the diagnosis of acute appendicitis in children. Acta Chir Scand (1986) 1.06
Immunogenicity in infants of a vaccine composed of Haemophilus influenzae type b capsular polysaccharide mixed with DPT or conjugated to diphtheria toxoid. J Infect Dis (1987) 1.06
Neonatal Candida parapsilosis outbreak with a high case fatality rate. Pediatr Infect Dis J (1995) 1.05
Chloroquine-resistant malaria from Angola. Lancet (1984) 1.04
Meningococcus group A vaccine in children three months to five years of age. Adverse reactions and immunogenicity related to endotoxin content and molecular weight of the polysaccharide. J Pediatr (1978) 1.04
Duration of rubella immunity induced by two-dose measles, mumps and rubella (MMR) vaccination. A 15-year follow-up in Finland. Vaccine (2000) 1.03
Acute thrombocytopenic purpura following measles, mumps and rubella vaccination. A report on 23 patients. Acta Paediatr (1993) 1.03
A comparative study of osteomyelitis and purulent arthritis with special reference to aetiology and recovery. Infection (1984) 1.00
The usefulness of C-reactive protein levels in the identification of concurrent septic arthritis in children who have acute hematogenous osteomyelitis. A comparison with the usefulness of the erythrocyte sedimentation rate and the white blood-cell count. J Bone Joint Surg Am (1994) 0.99
Prevalence of diarrheagenic Escherichia coli in finns with or without diarrhea during a round-the-world trip. J Clin Microbiol (2000) 0.99
Antibody responses to four Haemophilus influenzae type b conjugate vaccines. Am J Dis Child (1991) 0.97
Allergic reactions to measles-mumps-rubella vaccination. Pediatrics (2001) 0.97
No measles in Finland. Lancet (1997) 0.97
Neonatal immunization: response to Haemophilus influenzae type b-tetanus toxoid conjugate vaccine. Pediatrics (1995) 0.97
Epidemiology of invasive Haemophilus influenzae type b disease. J Infect Dis (1992) 0.96
C-reactive protein as predictor of sequelae of meningitis. Lancet (1984) 0.95
Day-to-day reactogenicity and the healthy vaccinee effect of measles-mumps-rubella vaccination. Pediatrics (2000) 0.95
Efficacy of salbutamol in treatment of infant pertussis demonstrated by sound spectrum analysis. Lancet (1982) 0.95
Epidemiology of rubella in Finland. Euro Surveill (2004) 0.95
High antibody responses to booster doses of either Haemophilus influenzae capsular polysaccharide or conjugate vaccine after primary immunization with conjugate vaccines. J Infect Dis (1992) 0.95
Systemic Haemophilus influenzae infection in Finland. Clin Pediatr (Phila) (1984) 0.94
Immunogenicity of Haemophilus influenzae oligosaccharide-protein and polysaccharide-protein conjugate vaccination of children at 4, 6, and 14 months of age. Pediatrics (1989) 0.94
Rapidity of C-reactive protein in detecting potential septicemia. Pediatr Infect Dis (1983) 0.93
Multivariate prognostication in bacterial meningitis of childhood. Scand J Infect Dis (1987) 0.93
C-reactive protein in measles. J Trop Pediatr (1992) 0.91
Length of prediagnostic history related to the course and sequelae of childhood bacterial meningitis. Pediatr Infect Dis J (1993) 0.90
Sero- and subtypes of group B meningococci causing invasive infections in Finland in 1976-87. Scand J Infect Dis (1989) 0.89
Group-specific meningococcal vaccination and epidemics caused by other groups of meningococci. Lancet (1978) 0.89
Acute purulent arthritis in children. Scand J Infect Dis (1983) 0.89
Disappearance of epiglottitis during large-scale vaccination with Haemophilus influenzae type B conjugate vaccine among children in Finland. Laryngoscope (1994) 0.89
C-reactive protein is useful in distinguishing Gram stain-negative bacterial meningitis from viral meningitis in children. J Pediatr (1999) 0.88
Antibiotic treatment for acute haematogenous osteomyelitis of childhood: moving towards shorter courses and oral administration. Int J Antimicrob Agents (2011) 0.88
Immunogenicity and reactogenicity of four Haemophilus influenzae type b capsular polysaccharide vaccines in Finnish 24-month-old children. Pediatr Infect Dis J (1988) 0.87
Simultaneous administration of Haemophilus influenzae type b capsular polysaccharide-diphtheria toxoid conjugate vaccine with routine diphtheria-tetanus-pertussis and inactivated poliovirus vaccinations of childhood. Pediatr Infect Dis J (1988) 0.87
Controversies in the management of childhood meningitis. J Med Microbiol (1997) 0.87
Increase of vaccination coverage by mass media and individual approach: intensified measles, mumps, and rubella prevention program in Finland. Am J Epidemiol (1991) 0.87
Acute haematogenous osteomyelitis in children in Finland. Finnish Study Group. Ann Med (1993) 0.87
BCG vaccination as a cause of osteomyelitis and subcutaneous abscess. Arch Dis Child (1984) 0.86
Total elimination of measles in Finland. Ann Med (1998) 0.86
Safe immunization of allergic children against measles, mumps, and rubella. Am J Dis Child (1987) 0.86
Slow recovery of cerebrospinal fluid glucose and protein concentrations distinguish pneumococcal from Haemophilus influenzae and meningococcal meningitis in children. Pediatr Infect Dis J (1995) 0.86
Pneumococcaemia complicated by meningitis. Arch Dis Child (1982) 0.86
C-reactive protein in rapid diagnosis and follow-up of bacterial septicemia in children with leukemia. Pediatr Infect Dis (1983) 0.85
Clinical experience with Haemophilus influenzae type b conjugate vaccines. Pediatrics (1990) 0.85
[Generalized infection and inflammatory meningitis caused by bacteria and fungi in Finland. Findings on blood and cerebrospinal fluid culture 1976-80]. Duodecim (1982) 0.84
Disseminated lung opacities and cavitation associated with Strongyloides stercoralis and Schistosoma mansoni infection. Am J Trop Med Hyg (1974) 0.84
Algorithms for the search of amino acid patterns in nucleic acid sequences. Nucleic Acids Res (1986) 0.84
Quantitative C-reactive protein (CRP) determined by an immunoturbidimetric method in rapid differential diagnosis of acute bacterial and viral diseases of children. Acta Paediatr Scand (1984) 0.84
Management of a child with suspected acute septic arthritis. Arch Dis Child (2011) 0.84
Adverse reactions and endotoxin content of polysaccharide vaccines. Dev Biol Stand (1977) 0.83
Twice vaccinated recipients are better protected against epidemic measles than are single dose recipients of measles containing vaccine. J Epidemiol Community Health (1999) 0.82